相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor- Modulator (SPPARM), in Dyslipidemic Patients with Renal Impairment
Koutaro Yokote et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interactions between Host PPARs and Gut Microbiota in Health and Disease
Arif Ul Hasan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome
Tsukasa Nozu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
Giuseppe Derosa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Nadia Bougarne et al.
ENDOCRINE REVIEWS (2018)
The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
Pengfei Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The antagonistic effect of selenium on cadmium-induced apoptosis via PPAR-γ/PI3K/Akt pathway in chicken pancreas
Xi Jin et al.
JOURNAL OF HAZARDOUS MATERIALS (2018)
Insights into the role of hepatocyte PPARα activity in response to fasting
Marion Regnier et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Fan Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity
Patricia Corrales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor
Yi Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Peroxisome Proliferator-Activated Receptors (PPAR) Agonists as Master Modulators of Tumor Tissue
Daniel Heudobler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells
Chao Zhang et al.
MOLECULES (2018)
Fasting Imparts a Switch to Alternative Daily Pathways in Liver and Muscle
Kenichiro Kinouchi et al.
CELL REPORTS (2018)
Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics
William James Deardorff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics
William James Deardorff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice
Zhijie Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance
Geoffrey A. Preidis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Vanessa Dubois et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury
Mei Liu et al.
JOURNAL OF NEUROTRAUMA (2017)
Melatonin prevents obesity through modulation of gut microbiota in mice
Pengfei Xu et al.
JOURNAL OF PINEAL RESEARCH (2017)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
ADAMTS1-mediated targeting of TSP-1 by PPARδ suppresses migration and invasion of breast cancer cells
Sun Ah Ham et al.
ONCOTARGET (2017)
DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice
Jing Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
Pengfei Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
PPARβ Is Essential for Maintaining Normal Levels of PGC-1α and Mitochondria and for the Increase in Muscle Mitochondria Induced by Exercise
Jin-Ho Koh et al.
CELL METABOLISM (2017)
PPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytes
Yong Pu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Swati Agarwal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Ting-Wei Lee et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Dual Outcomes of Rosiglitazone Treatment on Fatty Liver
Mingming Gao et al.
AAPS JOURNAL (2016)
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Nadira Ruzehaji et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
Nathalie Hennuyer et al.
ATHEROSCLEROSIS (2016)
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
Shun Ishibashi et al.
ATHEROSCLEROSIS (2016)
Leucine stimulates PPARβ/δ-dependent mitochondrial biogenesis and oxidative metabolism with enhanced GLUT4 content and glucose uptake in myotubes
Jamie K. Schnuck et al.
BIOCHIMIE (2016)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Alexandra Montagner et al.
GUT (2016)
T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease
Ming Tong et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Semir Beyaz et al.
NATURE (2016)
High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
Julie Tomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
Manuel Vazquez-Carrera
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
A Mathematical Model of the Liver Circadian Clock Linking Feeding and Fasting Cycles to Clock Function
Aurore Woller et al.
CELL REPORTS (2016)
PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
X. Wang et al.
ONCOGENESIS (2016)
Adipose Tissue Remodeling: its Role in energy Metabolism and Metabolic Disorders
Sung Sik Choe et al.
FRONTIERS IN ENDOCRINOLOGY (2016)
Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals
Alexandra Montagner et al.
SCIENTIFIC REPORTS (2016)
PPARs and ERRs: molecular mediators of mitochondrial metabolism
Weiwei Fan et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Saroglitazar for the treatment of dyslipidemia in diabetic patients
Shashank R. Joshi
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor Agonist Treatment Reduces Amyloid Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
Rebecca Skerrett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak et al.
JOURNAL OF HEPATOLOGY (2015)
Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice
Tamiris Lima Rachid et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Pioglitazone May Impair L-DOPA Anti-Parkinsonian Efficacy in the MPTP-Lesioned Macaque: Results of a Pilot Study
Philippe Huot et al.
SYNAPSE (2015)
Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation
L. Li et al.
CELL DEATH & DISEASE (2015)
Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment
Xiaohua Li et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Human Muscle Fiber Type-Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes
Peter H. Albers et al.
DIABETES (2015)
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Daniel Levin et al.
DIABETOLOGIA (2015)
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Alexander S. Banks et al.
NATURE (2015)
Maternal High-Fat Diet Modulates Hepatic Glucose, Lipid Homeostasis and Gene Expression in the PPAR Pathway in the Early Life of Offspring
Jia Zheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
Lazar A. Bojic et al.
JOURNAL OF LIPID RESEARCH (2014)
PPARγ and the global map of adipogenesis and beyond
Martina I. Lefterova et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
Jean-Charles Fruchart
CARDIOVASCULAR DIABETOLOGY (2013)
Reprogramming of the Circadian Clock by Nutritional Challenge
Kristin L. Eckel-Mahan et al.
CELL (2013)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats
Elnaz Karimian Azari et al.
PLOS ONE (2013)
Lipid Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol Characteristics of Metabolic Syndrome
Eric J. Olson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Li Qiang et al.
CELL (2012)
Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet
Megumi Hatori et al.
CELL METABOLISM (2012)
Thiazolidinediones and PPARγ agonists: time for a reassessment
Bertrand Cariou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
B. K. He et al.
PPAR RESEARCH (2012)
Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
Preeti Raval et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Role of Lipid Peroxidation and PPAR-δ in Amplifying Glucose-Stimulated Insulin Secretion
Guy Cohen et al.
DIABETES (2011)
Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
Bertrand Cariou et al.
DIABETES CARE (2011)
The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
Emma Barroso et al.
ENDOCRINOLOGY (2011)
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
Eva Moran-Salvador et al.
FASEB JOURNAL (2011)
Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
Jonathan P. Whitehead
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
Sihao Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
Tsuyoshi Goto et al.
JOURNAL OF LIPID RESEARCH (2011)
Fasting Induces the Expression of PGC-1α and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney
Christina T. Teng et al.
PLOS ONE (2011)
The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans
Ashish Shah et al.
ATHEROSCLEROSIS (2010)
Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells
Jun Wan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
PPARs: diverse regulators in energy metabolism and metabolic diseases
Yong-Xu Wang
CELL RESEARCH (2010)
Inhibition of adipocyte differentiation and adipogenesis by the traditional Chinese herb Sibiraea angustata
Lei Xiao et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
PPARα contributes to colonic protection in mice with DSS-induced colitis
Yasu-Taka Azuma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Endogenous Ligands for Nuclear Receptors: Digging Deeper
Michael Schupp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
Linda M. Sanderson et al.
PHYSIOLOGICAL GENOMICS (2010)
Role of PPAR alpha in Hepatic Carbohydrate Metabolism
Annelies Peeters et al.
PPAR RESEARCH (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
Carlos L. J. Vrins et al.
JOURNAL OF LIPID RESEARCH (2009)
PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
Giuseppe Bellelli et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Regulation of Peroxisome Proliferator-Activated Receptor-β/δ by the APC/β-CATENIN Pathway and Nonsteroidal Antiinflammatory Drugs
Jennifer E. Foreman et al.
MOLECULAR CARCINOGENESIS (2009)
Effect of fasting on PPARγ and AMPK activity in adipocytes
Kazuo Kajita et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
Xiaomei Qin et al.
HEPATOLOGY (2008)
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Steven J. Bensinger et al.
NATURE (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus
A. Hiukka et al.
DIABETOLOGIA (2007)
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor α agonists
Yukiyoshi Yamazaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting
Heleen M. van den Bosch et al.
BMC GENOMICS (2007)
PPARs and molecular mechanisms of transrepression
Mercedes Ricote et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Adipocytes as regulators of energy balance and glucose homeostasis
Evan D. Rosen et al.
NATURE (2006)
PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes
Michael Schuler et al.
CELL METABOLISM (2006)
From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
JN Feige et al.
PROGRESS IN LIPID RESEARCH (2006)
PPARδ regulates glucose metabolism and insulin sensitivity
CH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of long-term fenofibrate therapy on cardiovascular events among 9795 people with type 2 diabetes mellitus: The FIELD study, a randomised controlled trial
A. Keech
ATHEROSCLEROSIS SUPPLEMENTS (2006)
Ciglitazone-induced p27 gene transcriptional activity is mediated through Sp1 and is negatively regulated by the MAPK signaling pathway
F Chen et al.
CELLULAR SIGNALLING (2005)
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone - A preliminary study
GS Watson et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice
SZ Duan et al.
CIRCULATION RESEARCH (2005)
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Alexander Tenenbaum et al.
CARDIOVASCULAR DIABETOLOGY (2005)
A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes
BN Finck et al.
CELL METABOLISM (2005)
Hic-5 regulates an epithelial program mediated by PPARγ
S Drori et al.
GENES & DEVELOPMENT (2005)
PPARs and the complex journey to obesity
RM Evans et al.
NATURE MEDICINE (2004)
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth
RA Gupta et al.
NATURE MEDICINE (2004)
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
F Picard et al.
NATURE (2004)
The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells
U Dressel et al.
MOLECULAR ENDOCRINOLOGY (2003)
Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells
M Hoekstra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2003)
Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators
N Vu-Dac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Peroxisome proliferator-activated receptor α (PPARα)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice
T Kok et al.
BIOCHEMICAL JOURNAL (2003)
C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway
ED Rosen et al.
GENES & DEVELOPMENT (2002)
PPAR-α-null mice are protected from high-fat diet-induced insulin resistance
M Guerre-Millo et al.
DIABETES (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
SW Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study
Z Schlesinger et al.
CIRCULATION (2000)
Activation of PPARδ alters lipid metabolism in db/db mice
MD Leibowitz et al.
FEBS LETTERS (2000)
A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions
RG Mehta et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
